MedTrace Logo

Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study

NCT03405909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 517

Last updated 2021-03-02

No results posted yet for this study

Summary

Aim of this prospective national multicenter study is to improve standardization of contrast-enhanced ultrasound (CEUS) in the non-invasive diagnosis of hepatocellular carcinoma (HCC) in high-risk patients.

The study is funded by the German Society for Ultrasound in Medicine (DEGUM).

Conditions

Interventions

DIAGNOSTIC_TEST

contrast enhanced ultrasound (CEUS)

CEUS with SonoVue following standardized protocol

DIAGNOSTIC_TEST

MRI

CE-MRI following standardized protocol

DIAGNOSTIC_TEST

Histology

diagnostic liver biopsy

Sponsors & Collaborators

  • University Hospital Erlangen

    lead OTHER

Principal Investigators

  • Barbara Schellhaas, MD · University Hospital Erlangen, Department of Medicine 1

  • Deike Strobel, MD · University Hospital Erlangen, Department of Medicine 1

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-21
Primary Completion
2019-04-06
Completion
2019-04-06

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03405909 on ClinicalTrials.gov